Profound Medical Corp.PROFEarnings & Financial Report
CompuGroup Medical SE & Co. KGaA is a German publicly listed software company based in Koblenz that develops and offers software for the healthcare sector. It produces cloud-based and digital application software to support medical and organizational activities in doctors' practices, pharmacies, medical laboratories and hospitals. According to its own figures, the company employed more than 9,200 people worldwide in 2022, and has over 1.6 million users in 56 countries. CompuGroup Medical shar...
PROF Q4 FY2025 Key Financial Metrics
Revenue
$6.0M
Gross Profit
$4.0M
Operating Profit
$-7.4M
Net Profit
$-8.2M
Gross Margin
66.8%
Operating Margin
-123.3%
Net Margin
-136.8%
YoY Growth
N/A
EPS
$0.27
Profound Medical Corp. Q4 FY2025 Financial Summary
Profound Medical Corp. reported revenue of $6.0M for Q4 FY2025, with a net profit of $-8.2M (-136.8% margin). Cost of goods sold was $2.0M, operating expenses totaled $11.4M.
Key Financial Metrics
| Total Revenue | $6.0M |
|---|---|
| Net Profit | $-8.2M |
| Gross Margin | 66.8% |
| Operating Margin | -123.3% |
| Report Period | Q4 FY2025 |
Profound Medical Corp. Annual Revenue by Year
Profound Medical Corp. annual revenue history includes year-by-year totals (for example, 2025 revenue was $15.4M).
Profound Medical Corp. Quarterly Revenue & Net Profit History
Profound Medical Corp. results over the last 4 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $6.0M | — | $-8.2M | -136.8% |
| Q3 FY2025 | $5.1M | — | $-8.0M | -157.7% |
| Q2 FY2025 | $2.0M | — | $-15.7M | -792.3% |
| Q1 FY2025 | $2.3M | — | $-10.7M | -458.1% |
Income Statement
| Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|
| Revenue | $2.3M | $2.0M | $5.1M | $6.0M |
| YoY Growth | N/A | N/A | N/A | N/A |
Balance Sheet
| Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|
| Assets | $60.9M | $49.7M | $42.3M | $77.5M |
| Liabilities | $10.1M | $10.4M | $10.2M | $11.0M |
| Equity | $50.8M | $39.3M | $32.1M | $66.4M |
Cash Flow
| Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|
| Operating CF | $-8.3M | $-13.7M | $-9.6M | $-6.6M |